These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31042676)

  • 1. Arg-Leu-Tyr-Glu Suppresses Retinal Endothelial Permeability and Choroidal Neovascularization by Inhibiting the VEGF Receptor 2 Signaling Pathway.
    Park W; Baek YY; Kim J; Jo DH; Choi S; Kim JH; Kim T; Kim S; Park M; Kim JY; Won MH; Ha KS; Kim JH; Kwon YG; Kim YM
    Biomol Ther (Seoul); 2019 Sep; 27(5):474-483. PubMed ID: 31042676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism.
    Baek YY; Lee DK; Kim J; Kim JH; Park W; Kim T; Han S; Jeoung D; You JC; Lee H; Won MH; Ha KS; Kwon YG; Kim YM
    Oncotarget; 2017 Feb; 8(7):11763-11777. PubMed ID: 28052029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Efficacy of a Novel Acetylated Tetrapeptide in Animal Models of Age-Related Macular Degeneration.
    Koo HC; Baek YY; Choi JS; Kim YM; Sung B; Kim MJ; Kim JG; You JC
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases.
    Yun JA; Kim J; Baek YY; Park W; Park M; Kim S; Kim T; Choi S; Jeoung D; Lee H; Won MH; Kim JY; Ha KS; Kwon YG; Kim YM
    Mol Pharmacol; 2019 Dec; 96(6):692-701. PubMed ID: 31594790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasminogen-derived N-acetyl-Arg-Leu-Tyr-Glu antagonizes VEGFR-2 to prevent blood-retinal barrier breakdown in diabetic mice.
    Park W; Kim J; Choi S; Kim T; Park M; Kim S; You JC; Kim JH; Ha KS; Lee JH; Kwon YG; Kim YM
    Biomed Pharmacother; 2021 Feb; 134():111110. PubMed ID: 33338749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tetrapeptide Arg-Leu-Tyr-Glu inhibits VEGF-induced angiogenesis.
    Baek YY; Lee DK; So JH; Kim CH; Jeoung D; Lee H; Choe J; Won MH; Ha KS; Kwon YG; Kim YM
    Biochem Biophys Res Commun; 2015 Aug; 463(4):532-7. PubMed ID: 26051280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation.
    Lee HS; Jun JH; Jung EH; Koo BA; Kim YS
    Molecules; 2014 Aug; 19(8):12150-72. PubMed ID: 25123184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
    Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
    Elife; 2020 Apr; 9():. PubMed ID: 32312382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L; Chen H; Tuo J; Gao X; Chen L
    Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
    Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of microRNA-155 attenuates retinal neovascularization via the PI3K/Akt pathway.
    Zhuang Z; Xiao-qin ; Hu H; Tian SY; Lu ZJ; Zhang TZ; Bai YL
    Mol Vis; 2015; 21():1173-84. PubMed ID: 26539029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BET Bromodomain Suppression Inhibits VEGF-induced Angiogenesis and Vascular Permeability by Blocking VEGFR2-mediated Activation of PAK1 and eNOS.
    Huang M; Qiu Q; Xiao Y; Zeng S; Zhan M; Shi M; Zou Y; Ye Y; Liang L; Yang X; Xu H
    Sci Rep; 2016 Apr; 6():23770. PubMed ID: 27044328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triamcinolone Acetonide Suppresses Inflammation and Facilitates Vascular Barrier Function in Human Retinal Microvascular Endothelial Cells.
    Imai S; Otsuka T; Naito A; Shimazawa M; Hara H
    Curr Neurovasc Res; 2017; 14(3):232-241. PubMed ID: 28625129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockout of αA-crystallin inhibits ocular neovascularization.
    Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Administration of a Novel Acetylated Tetrapeptide Suppresses Vascular Permeability and Immune Responses and Alleviates Atopic Dermatitis in a Murine Model.
    Sung B; Baek YY; Kim YM; You JC
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
    Castro MR; Lutz D; Edelman JL
    Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.
    Balser C; Wolf A; Herb M; Langmann T
    J Neuroinflammation; 2019 Feb; 16(1):26. PubMed ID: 30732627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization.
    Liu X; Guo A; Tu Y; Li W; Li L; Liu W; Ju Y; Zhou Y; Sang A; Zhu M
    Cell Death Dis; 2020 Nov; 11(11):1016. PubMed ID: 33247124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.